- Home
- STAA vs OMCL Comparison
STAA vs OMCL Comparison
Compare STAA & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STAA
- OMCL
- Stock Information
- Founded
- STAA 1982
- OMCL 1992
- Country
- STAA United States
- OMCL United States
- Employees
- STAA N/A
- OMCL N/A
- Industry
- STAA Ophthalmic Goods
- OMCL Computer Manufacturing
- Sector
- STAA Health Care
- OMCL Technology
- Exchange
- STAA Nasdaq
- OMCL Nasdaq
- Market Cap
- STAA 1.4B
- OMCL 1.5B
- IPO Year
- STAA N/A
- OMCL 2001
- Fundamental
- Price
- STAA $27.88
- OMCL $31.83
- Analyst Decision
- STAA Hold
- OMCL Buy
- Analyst Count
- STAA 8
- OMCL 7
- Target Price
- STAA $22.50
- OMCL $46.71
- AVG Volume (30 Days)
- STAA 720.4K
- OMCL 516.0K
- Earning Date
- STAA 10-29-2025
- OMCL 10-29-2025
- Dividend Yield
- STAA N/A
- OMCL N/A
- EPS Growth
- STAA N/A
- OMCL N/A
- EPS
- STAA N/A
- OMCL 0.49
- Revenue
- STAA $224,449,000.00
- OMCL $1,149,529,000.00
- Revenue This Year
- STAA N/A
- OMCL $5.37
- Revenue Next Year
- STAA $27.59
- OMCL $3.67
- P/E Ratio
- STAA N/A
- OMCL $67.26
- Revenue Growth
- STAA N/A
- OMCL 6.39
- 52 Week Low
- STAA $13.50
- OMCL $22.66
- 52 Week High
- STAA $38.60
- OMCL $55.75
- Technical
- Relative Strength Index (RSI)
- STAA 68.21
- OMCL 50.28
- Support Level
- STAA $27.52
- OMCL $31.73
- Resistance Level
- STAA $28.38
- OMCL $33.32
- Average True Range (ATR)
- STAA 0.45
- OMCL 0.95
- MACD
- STAA -0.30
- OMCL -0.16
- Stochastic Oscillator
- STAA 63.14
- OMCL 17.84
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.